Clinical Trial Update: A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China

View source ↗

Summary

This clinical trial update reports a completed real-world study in China examining adjuvant therapy for early-stage non-small cell lung cancer with EGFR mutatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: NSCLC, Stage I, NSCLC, Stage II | Status: COMPLETED